Shlomo Yanai's Net Worth

$3.69 Million

Estimate Recalculated Nov 11, 2024 02:50AM EST

Who is Shlomo Yanai?

Shlomo Yanai has an estimated net worth of $3.69 Million. This is based on reported shares across multiple companies, which include Philip Morris International Inc., Sagent Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., PERRIGO Co plc, Protalix BioTherapeutics, Inc., Exela Technologies, Inc., CAMBREX CORP, PDL BIOPHARMA, INC., and W R GRACE & CO.

SEC CIK

Shlomo Yanai's CIK is 0001562645

Past Insider Trading and Trends

2019 was Shlomo Yanai's most active year for acquiring shares with 20 total transactions. Shlomo Yanai's most active month to acquire stocks was the month of April. 2016 was Shlomo Yanai's most active year for disposing of shares, totalling 5 transactions. Shlomo Yanai's most active month to dispose stocks was the month of April. 2019 saw Shlomo Yanai paying a total of $1,015,306.48 for 209,243 shares, this is the most they've acquired in one year. In 2019 Shlomo Yanai cashed out on 35,796 shares for a total of $2,147,760.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Philip Morris International Inc. (PM) Snapshot price: $125.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+31.32%
1.79K
$97.84
$175,035.76
7.5K
May 8
Form 4
+49.05%
1.81K
$96.58
$175,002.96
5.51K
May 3
Form 4
+95.65%
1.76K
$99.53
$175,073.27
3.6K
May 4
Form 4
∞
1.84K
$95.18
$175,026.83
1.84K
May 5
Form 3
—
0
—
—
0
No matching records found

Sagent Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-742.00
$21.75
-$16,138.50
0
Aug 29
Form 4
∞
742
—
—
742
Apr 15
Form 4
—
0
—
—
0
Feb 22
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Apr 15
No matching records found

Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $8.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+45.17%
76.45K
—
—
245.73K
May 10
Form 4
—
0
—
—
0
May 2
Form 4
+89.88%
80.13K
—
—
169.27K
May 9 - May 10
Form 4
+65.88%
35.41K
—
—
89.15K
May 8 - May 9
Form 4
+614.44%
46.22K
—
—
53.74K
May 5 - May 6
Form 4
∞
7.52K
—
—
7.52K
Dec 15
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

PERRIGO Co plc (PRGO) Snapshot price: $27.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 19
Form 4
∞
443
$95.70
$42,395.10
443
May 4
Form 4
—
0
—
—
0
Nov 4
Form 3
—
0
—
—
0
No matching records found

Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 24
Form 3
—
0
—
—
0
No matching records found